Table 5.

Changes in hepatorenal levels in two groups (mean ± SD).

		CG	IG	Ft/Pt	Fg/Pg	Fi/P i
ALT (U/L)	Pre	21.07 ± 10.17	20.50 ± 5.70	0.601/0.443	0.666/0.419	0.827/0.369
	Week 12	21.26 ± 10.62	19.03 ± 8.28
	△	0.19 ± 7.59	-1.47 ± 8.18	0.958/0.341
AST (U/L)	Pre	18.50 ± 7.03	20.27 ± 6.90	10.674/<0.01	0.131/0.719	3.716/0.061
	Week 12	18.10 ± 6.77	17.47 ± 4.25 *
	F	0.341	10.421
	P	0.563	<0.01
	△	-0.40 ± 4.49	-2.80 ± 5.55†	2.161/0.034
TP (g/L)	Pre	71.33 ± 5.06	69.66 ± 4.44	1.331/0.256	10.502/<0.01	6.180/0.017
	Week 12	72.24 ± 4.29	67.35 ± 5.42† *
	F	1.110	6.718
	P	0.298	0.013
	△	0.91 ± 5.60	-2.31 ± 5.70†	2.595/0.011
ALB (g/L)	Pre	44.80 ± 3.26	43.72 ± 3.17	5.138/0.029	14.507/<0.01	19.719/<0.01
	Week 12	45.31 ± 3.61	41.91 ± 3.47† *
	F	2.604	16.283
	P	0.114	<0.01
	△	0.50 ± 2.02	-1.81 ± 2.88†	4.236/<0.01
TBIL (µmol/L)	Pre	9.69 ± 4.09	10.29 ± 2.28	2.754/0.105	0.033/0.857	1.608/0.212
	Week 12	10.82 ± 5.03	10.48 ± 2.75
	△	1.12 ± 4.50	0.19 ± 2.34	1.186/0.240
ALP (U/L)	Pre	100.12 ± 21.14	101.10 ± 18.53	26.841/<0.01	0.705/0.406	1.765/0.192
	Week 12	94.76 ± 21.80	88.02 ± 17.41 *
	F	2.552	14.696
	P	0.118	<0.01
	△	-5.36 ± 21.73	-13.07 ± 21.84	1.613/0.111
BUN (mmol/L)	Pre	5.75 ± 1.23	5.53 ± 0.82	0.038/0.846	<0.01/0.995	2.053/0.160
	Week 12	5.61 ± 1.42	5.76 ± 1.01
	△	-0.15 ± 1.23	0.22 ± 1.24	-1.357/0.179
CREA (µmol/L)	Pre	74.06 ± 15.77	75.58 ± 15.23	24.203/<0.01	2.408/0.129	19.456/<0.01
	Week 12	73.98 ± 16.06	63.41 ± 13.60† *
	F	0.006	26.043
	P	0.940	<0.01
	△	-0.08 ± 6.92	-12.17 ± 15.26†	4.626/<0.01
UA (µmol/L)	Pre	328.08 ± 70.56	323.93 ± 84.13	0.012/0.913	0.041/0.840	2.777/0.103
	Week 12	320.91 ± 69.92	330.83 ± 66.91
	△	-7.16 ± 39.83	6.89 ± 40.35	-1.597/0.114

F_t/P_t , F_g/P_g , and F_i/P_i : two-way repeated measures ANOVA, time effect, group effect, and group. *time interaction;

†: P<0.05 vs. CG; *: P<0.05 vs. Pre; CG, control group; IG, intervention group.